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Summary: Childhood absence epilepsy (CAE) is an idiopathic generalised epilepsy (IGE) char-
acterised by typical absence seizures manifested by transitory loss of awareness with 2.5—4Hz
spike-wave complexes on ictal EEG. A genetic component to the aetiology is well recognised but
the mechanism of inheritance and the genes involved are yet to be fully established.
A genome wide single nucleotide polymorphism (SNP)-based high density linkage scan was carried
out using 41 nuclear pedigrees with at least two affected members. Multipoint parametric and
non-parametric linkage analyses were performed using MERLIN 1.1.1 and a susceptibility locus
was identiﬁed on chromosome 3p23-p14 (Zmean = 3.9, p < 0.0001; HLOD= 3.3, ˛ = 0.7). The linked
region harbours the functional candidate genes TRAK1 and CACNA2D2. Fine-mapping using a
ed d
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2002; Sugimoto et al., 2000; Wallace et al., 2001). We have
previously shown evidence for linkage and association totagSNP approach demonstrat
© 2009 Elsevier B.V. All right
ntroduction
he absence epilepsies are a group of idiopathic generalised
pilepsies (IGEs) which differ in their seizure frequency, age
f onset and pattern of evolution. A typical absence seizure
anifests as a transitory loss of awareness with 2.5—4Hz
pike-wave complexes on ictal EEG. Many patients also
ave generalised tonic—clonic seizures (GTCS), myoclonic
eizures or febrile seizures in addition and a variety of ‘atyp-
cal’ absence seizures are recognised. The International
eague Against Epilepsy (ILAE) classiﬁcation recognises a
umber of distinct absence epilepsy syndromes including
hildhood absence epilepsy (CAE), juvenile absence epilepsy
JAE), epilepsy with myoclonic absences, juvenile myoclonic
pilepsy (JME) and eyelid myoclonia with absences as a
eizure type (Engel, 2001). However, it is still unclear
hether these syndromes represent a ‘biological continuum’
r distinct entities. Frequency of absence seizures per day
s greater in CAE than JAE, and the occurrence of GTCS is
reater in patients with JAE than CAE. However, there is evi-
ence that CAE and JAE share a close genetic relationship
llowing them to be considered as one phenotype in genetic
tudies (Berkovic et al., 1987; Marini et al., 2004).
c
c
i
i
iisease association with variants in TRAK1.
erved.
Twin studies have demonstrated that the IGEs, includ-
ng those in which absence seizures occur, have a signiﬁcant
eritability (Berkovic et al., 1998), with regards to both
ccurrence and type of seizure and syndrome with concor-
ance rates for monozygotic twin pairs far higher than for
izygotic twin pairs (Kjeldsen et al., 2003). Absence epilep-
ies, along with the other common forms of IGE, show a
omplex pattern of inheritance. In keeping with other com-
on genetic disorders, this is expected to result from the
ction of a few or many genes of small to moderate effect.
Genome-wide linkage analysis of IGE-multiplex families
as demonstrated evidence for susceptibility loci on chro-
osomes 2q36, 3q26, and 14q23 (Sander et al., 2000).
urthermore, loci for three similar forms of absence epilepsy
ave been identiﬁed on chromosomes 8q24 (ECA1), 5q31.1
ECA2) and 3q26 (ECA3) (Fong et al., 1998; Robinson et al.,hromosome 16p12-p13.1, the region containing the calcium
hannel gene CACNG3 (Everett et al., 2007). An association
n humans has been documented between polymorphisms
n CACNA1A (chromosome 19p13.2-p13.1) and IGE includ-
ng CAE (Chioza et al., 2001). Twelve missense mutations in
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CACNA1H (chromosome 16p13.3) have been found in 14 spo-
radic Chinese Han patients with CAE but not in any of 230
unrelated controls (Chen et al., 2003). Mutations in three
GABA receptor genes have been identiﬁed in families with
CAE (sometimes in conjunction with other seizure types):
GABRG2 (Wallace et al., 2001); GABRA1 (Maljevic et al.,
2006); GABRB3 (Feucht et al., 1999; Tanaka et al., 2008).
Four mouse models of spike-wave epilepsy are caused
by mutations in genes for different subunits of voltage-
gated calcium channels (VGCCs): tottering tg, Cacna1a
(Fletcher et al., 1996); lethargic lh, Cacnb4 (Burgess et al.,
1997); stargazer stg, CACNG2 (Letts et al., 1998); ducky
du, Cacna2d2 (Barclay et al., 2001). The du mutation is
a genomic rearrangement resulting in the introduction of
a premature stop codon and predicting the expression of
a truncated protein encoded by the ﬁrst three exons of
Cacna2d2, followed by 8 novel amino acids.
This body of evidence indicates that the majority of idio-
pathic human and animal epilepsies are channelopathies,
with implicated genes likely to be either ion channel genes
or genes for related molecules (see for review Weber and
Lerche, 2008).
The aim of this work was to identify disease-predisposing
loci by undertaking a genome-wide SNP-based linkage scan
using nuclear pedigrees which had at least two affected
members (a proband with CAE and at least one other
non-parental relative with CAE or JAE). A SNP-based
approach provides increased genomic coverage and over-
all provided a greater information content in comparison
to microsatellites (Evans and Cardon, 2004; John et al.,
2004). A ‘‘model-free’’ non-parametric analysis was ini-
tially performed followed by speciﬁc parametric analyses.
Fine-mapping of candidate genes was performed using a
tagSNP approach, combined with re-sequencing of the cod-
ing regions and regulatory regions.
We report here the identiﬁcation of a susceptibility
locus for CAE on chromosome 3 and further analysis of
two positional and functional candidate genes, TRAK1 and
CACNA2D2. Evidence for disease association was shown for
variants in TRAK1 and a putative causal variant has been
investigated.
Materials and methods
Subjects and samples
63 nuclear pedigrees (with a total of 323 individuals; 133 CAE
and 7 JAE cases) and 296 trios (affected child and both parents)
were ascertained from populations with European ancestry includ-
ing the UK, France, Germany, Austria, Greece, The Netherlands,
Denmark, Sweden, Finland, Italy and North America. Appropriate
informed consent was obtained from all participants. Full protocol
and consent form approval was obtained from local research ethics
committees and/or participating institutions as appropriate.
Details of the clinical data on subjects categorised as affected
have been published previously (Everett et al., 2007). Inclusion cri-
teria for CAE, based on the ILAE classiﬁcation, were as follows:
age of onset between 3 and 10 years; normal neurological state
and development; brief and often frequent absence seizures with
abrupt and severe impairment of consciousness; automatisms may
occur; mild myoclonic jerks of the eyes, eyebrows or eyelids may
occur; generalised tonic—clonic seizures may occur; seizures may
persist into adulthood; the ictal EEG shows bilateral, synchronous,
r
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ymmetrical discharges of 2.5—4Hz spike-wave complexes on a nor-
al background or polyspike-wave complexes; photosensitivity may
e present. Exclusion criteria included: signiﬁcant developmental
elay; persistent or focal neurological deﬁcit; clear abnormali-
ies on neuroimaging. Inclusion criteria for JAE were as follows:
ge of onset between 10 and 17 years; normal neurological state
nd development; brief absence seizures with abrupt and severe
mpairment of consciousness occurring sporadically; generalised
onic—clonic seizures may occur possibly as the initial seizure type;
ild myoclonic jerks may occur; ictal EEG of symmetrical, gener-
lised spike-wave discharges more prominent in the frontal region
t a frequency of 3.5—4.5Hz; photosensitivity may occur. Exclusion
riteria include prominent bilateral myoclonic seizures as occur in
uvenile myoclonic epilepsy.
Genomic DNA was extracted from cheek swab, saliva or blood
amples according to standard kits and protocols (OrageneTM and
imhelix DNA Isolation kits). 237 of the 304 samples used in
he genome-wide screen were whole genome ampliﬁed (WGA) as
equired using the REPLI-g® kit.
Control samples were obtained from the European Collection
f Cell Cultures (ECACC) human random control panels 1, 2 and 3
HRC-1, HRC-2 and HRC-3; 94 samples per plate). The ECACC HRC
anels include DNA from blood donors who are all UK Caucasians
nd are characterised by gender and age at venesection. All donors
ave given written informed consent for their blood to be used for
esearch purposes. Conformation to Hardy—Weinberg Equilibrium
HWE) was veriﬁed in all SNPs typed in controls.
enotyping and linkage analysis
ata for linkage analysis was obtained from a successful genome-
ide screen in 240 samples from 41 of the original nuclear pedigrees
see Supplementary Table 1 for details of these 41 families). A high
ailure rate in WGA samples accounts for this loss of data. The
creen was performed using the Illumina Linkage V Panel of 6018
NPs. Illumina provide a GenCall score for every genotype. This
core is a quality metric that indicates reliability of the genotypes
alled with a maximum of 1. Quality control of the data was per-
ormed using the GenCall score; a median score of 0.7 was used as
he minimum acceptable value for a SNP to be used and the locus
ad to have been successfully typed in both genomic and WGA sam-
les to be included in analysis. A minimal call rate of 90% was used
eaving 4852 SNPs to be analysed. The average genetic distance
etween these SNPs was 0.77 cM and the average physical distance
as 582 kb. There were no signiﬁcant gaps on any chromosome.
Multipoint parametric and non-parametric linkage analyses were
erformed using the program MERLIN 1.1.1 (Abecasis et al., 2002)
ithin the analysis suite EasyLinkage v5.08 (Hoffmann and Lindner,
005). MERLIN 1.1.1 checks for and removes erroneous genotypes
rior to analysis. Non-parametric Zlr scores were calculated using
he Kong and Cox model (Kong and Cox, 1997) at each SNP loci, along
ith its corresponding p-value. The score is compared to a normal
istribution to test for deviation. The assumption of a normal distri-
ution is conservative as are the associated p-values (Whittemore
nd Halpern, 1994). Thresholds for suggestive evidence for linkage
nd signiﬁcant evidence for linkage were based on those suggested
y Lander and Kruglyak (1995) and are closely comparable. Sug-
estive linkage is deﬁned by a p-value < 10−3 and the threshold for
igniﬁcant linkage is a p-value < 10−4. These values are equivalent
o one-tailed Z scores of 3.1 and 3.7 respectively, which are them-
elves equivalent to maximised LOD scores of 2.4 and 3.3, which are
he values suggested for genome-wide linkage analysis. Paramet-
ic analysis was performed on those genomic regions which showed
igniﬁcant evidence for linkage using NPL analysis; autosomal dom-
nant inheritance with a penetrance of 50% was assumed. These
arameters correspond to the available data on Mendelian segre-
ation in this trait. They are conservative and the low penetrance
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educes the risk of false negative results. A disease allele frequency
f 0.01 and a phenocopy rate of 0.0001 were assumed. These values
re compatible with the observed population prevalence and sibling
ecurrence risk ratio attributable to the locus, based on the origi-
al calculations of Risch (1990). HLOD scores as well as an estimate
f ˛, which represents the proportion of pedigrees consistent with
inkage at a speciﬁc locus, were calculated.
andidate gene analysis
nowledge of the underlying pathophysiology of epilepsy is suf-
ciently advanced to allow evaluation of positional candidate
enes within the critical regions according to their expression and
utative function. Information was collected from a number of
uman genome resources including the Ensembl, National Center
or Biotechnology Information (NCBI) and University of California-
anta Cruz (UCSC) Browsers (genome build NCBI36.1), in addition
o the PubMed and Unigene databases. By searching through these
atabases, we identiﬁed the most probable functional candidate
enes.
All coding and UTR exons, as well as exon—intron junctions
sequencing 100 bp either side of each exon), in the best func-
ional candidates, were re-sequenced in 48 affected individuals
rom the multiple case pedigrees, using one case from each pedi-
ree. This re-sequencing work was performed by Polymorphic DNA
echnologies Inc., using standard Sanger dideoxy sequencing proto-
ols (http://www.polymorphicdna.com).Concurrent to the re-sequencing, tagSNPs were designed to
chieve full haplotype coverage of the best functional candidates.
he Tagger program (de Bakker et al., 2005) was run to identify
agSNPs. The program, using the degree of pair-wise linkage dise-
uilibrium (LD) as measured by a r2 ≥ 0.8 between unassayed and
u
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B
v
a
igure 1 Multipoint NPL Z scores for all chromosomes. Position re
he chromosome.B.A. Chioza et al.
ssayed SNPs in the HapMap (release 21 CEU genotype data), iden-
iﬁed the SNPs which would capture > 99% of all haplotypes. These
agSNPs were typed in the entire resource of nuclear pedigrees
nd trios and the genotypes were used to construct LD blocks with
aploview 3.2 (Barrett et al., 2005). Blocks were deﬁned as a solid-
pine of LD, i.e. the ﬁrst and last marker in a block are in strong LD
ith all intermediate markers (one slight mismatch is allowed by the
rogramme), but these intermediate markers are not necessarily in
D with one another. A minimum D′ of 0.7 was used as the cut-off
oint for strong LD. Intrafamilial association analysis was performed
n individual SNPs using the PDT (Martin et al., 2000, 2001, 2003).
he PDT produces two measures of association, the PDT-AVE and the
DT-SUM. The former gives all families equal weight in the analysis
hereas the latter gives more weight to more informative families.
The same sets of tagSNPs were also genotyped in 282 ECACC
ontrols and case—control analysis performed using the Pearson’s
hi-squared test or the Fisher Exact Test (when any of the cells in
he calculation table contained a value of 5 or less).
Association analysis of the tagSNPs allowed the identiﬁcation
f gene regions for re-sequencing which would not have been re-
equenced initially, e.g. intronic areas. The limits for re-sequencing
ere determined by the LD structure of the tagSNPs, i.e. re-
equencing was performed around any associated SNP as far as the
rst SNPs either side to which it was not in LD. This re-sequencing
as performed in the same 48 cases as exonic re-sequencing was
erformed in, by Polymorphic DNA Technologies.
Potential functional effects of identiﬁed variants were assessed
sing in silico methods, such as VisualSNP and FastSNP (Yuan et
l., 2006). Standard nucleotide—nucleotide and protein—protein
LAST searches were performed to assess the degree of conser-
ation across species and therefore to further assess how important
ny variant may be functionally.
fers to genetic distance from the telomere of the short arm of
Susceptibility locus for CAE on chromosome 3p23-p14
Results
Linkage analysis
The results of the multipoint NPL analysis for each chro-
mosome are shown in Fig. 1. Signiﬁcant evidence for
linkage was found to chromosome 3p22-p14 (NPL Zmax of
3.9, p < 0.0001). The critical region is arbitrarily deﬁned as
extending to where the Z score falls below 3; a region of
approximately 20 cM (Supplementary Table 2). This is a con-
servative approach to deﬁning the critical region so that no
possible candidate genes are overlooked; this region con-
tains 381 genes. Approximately 72% of families, based on
per family Z score, were consistent with linkage to chromo-
some 3. An expanded view of the linked region is shown in
Fig. 2.
Parametric analysis of chromosome 3 demonstrated
signiﬁcant evidence for linkage with a maximum HLOD
(HLODmax) of 3.3 (˛ = 0.7) occurring at 3p21 (Fig. 2).
Candidate gene analysis
Based on reported function, expression patterns and animal
models, we identiﬁed two highly plausible functional candi-
date genes within the chromosome 3p22-p14 linkage region:
TRAK1 and CACNA2D2.
Twenty tagSNPs were typed in CACNA2D2; 31 tagSNPs
were typed in TRAK1. These were selected to encompass
the full possible genomic region covered by the reported
transcripts in the NCBI database (Fig. 3a and b).
Intrafamilial and case—control association analysis of the
CACNA2D2 tagSNPs did not detect any evidence for over-
transmission of any alleles therefore CACNA2D2 was not
analysed further.
Intrafamilial association analysis on the entire resource
detected evidence for overtransmission of the minor allele
Figure 2 NPL Z score and parametric HLOD plots for chro-
mosome 3 for the region showing evidence for linkage; position
refers to genetic distance from the telomere of the short arm
of the chromosome. Each marked point corresponds to a geno-
typed SNP. Chromosome 3 was analysed under the assumption of
autosomal dominant inheritance, assuming a disease allele fre-
quency of 0.01 and a reduced penetrance of 0.5. Also shown,
with red lines, are the approximate positions of two candidate
genes, TRAK1 and CACNA2D2.
t
n
p
a
t
s
e
w
r
a
2
e
a
∼
(
i
b
r
T
r
N
r
t
n
v
a
l
p
w
c
s
D
C
a
p
m
c
t
c
c
b
(
t
i
d
c
C
b
H
f
s
c
r
c
a
w
d251
o affected offspring in two SNPs in TRAK1 (at the 95% sig-
iﬁcance level; Table 1). The LD block structure of TRAK1 as
redicted using Haploview is shown in Fig. 4. Both disease-
ssociated SNPs reside in block 2, a 5 kb region of high LD;
herefore it was decided to re-sequence this region at the
ame time as the coding regions as part of the re-sequencing
ffort. Re-sequencing of this so-called ‘‘associated block’’
as extended to the two ﬂanking SNPs (rs11709411 and
s9311300; see Figs. 3a and 4) in order to capture all vari-
nts that might be in LD with the associated SNPs in block
. Re-sequencing of this region (∼5.5 kb) and the coding
xons (and 100 bp either side), the 5′ and 3′ UTR regions,
nd 1 kb upstream and downstream of the gene (a total of
23.5 kb) identiﬁed 51 known variants and 16 novel variants
Supplementary Table 3 and Fig. 5). Based on bioinformat-
cs analysis, the variant in TRAK1 which currently seemed to
e the most likely to have a functional effect was a triplet
epeat in the ﬁnal exon of the shorter transcript NM 014965.
he repeat inserts additional glutamic acid residues in a
un of glutamic acid residues and has been reported in the
CBI SNP database as several different indels; rs10634555,
s35624871, rs10546421 and rs10530663. The repeat was
herefore genotyped in 96 ECCAC samples to ascertain the
umber of alleles and their frequency, and in all the indi-
iduals of the 63 pedigrees to determine any signiﬁcant
ssociation. The ECCAC sample genotyping showed four alle-
es with frequencies: 0.23, 0.24, 0.23 and 0.30. In the 63
robands from the pedigrees, the comparative frequencies
ere: 0.23, 0.29, 0.27 and 0.22. However, the results of the
ase—control and intrafamilial association analyses were not
tatistically signiﬁcant.
iscussion
hildhood absence epilepsy (CAE) is an idiopathic gener-
lised epilepsy (IGE) with a well deﬁned and homogeneous
henotype that displays a clear electrophysiological hall-
ark and clear evidence of a genetic aetiology. The clinical
riteria adopted here provide the reasonable expectation
hat the patients ascertained represent a homogenous clini-
al phenotype. It is has been shown that IGE phenotypes may
luster in families with a proband with absence epilepsy,
ut analysis reveals an increased clustering of CAE and JAE
Berkovic et al., 1987; Marini et al., 2004) suggesting that
hey may share susceptibility loci. For this reason, pedigrees
n which ﬁrst degree relatives of a proband with CAE had a
iagnosis of JAE were included and such individuals were
ategorised as affected (6 of the 63 pedigrees).
We have identiﬁed a novel susceptibility locus for
AE/JAE on chromosome 3p23-p14 through a SNP-
ased genome-wide linkage scan (Zmean = 3.9, p < 0.0001;
LOD= 3.3, ˛ = 0.7). This is the only region of the genome
or which there is a signiﬁcant linkage score in our analy-
is. The linkage peaks on chromosomes 9 and 17 which are
lose to being statistically suggestive of linkage might war-
ant some attention in future in context of the genetically
omplex architecture of IGE syndromes.
The parametric analysis of chromosome 3 indicates that
large proportion of our pedigrees (∼70%) are consistent
ith linkage to chromosome 3p23-p14. We have previously
emonstrated evidence for linkage to 16p12-p13.1, a region
252 B.A. Chioza et al.
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rigure 3 (a and b) TagSNPs for TRAK1 and CACNA2D2. Unde
ith intra-familial association analysis using the PDT.
ontaining the calcium channel gene CACNG3, using a simi-
ar resource of CAE/JAE families (Everett et al., 2007). CAE
s a complex trait and therefore we expect signiﬁcant locus
eterogeneity, with it being quite possible that any family
r individual may have a contribution from more than one
ocus. Twenty-one pedigrees are consistent with linkage to
oth the 16p12-p13.1 locus and the 3p23-p14 locus identi-
ed in the current study. It is possible that this is suggestive
f interaction between two loci culminating in increased
eizure susceptibility. There is some evidence from mouse
odels that different genes can interact and alter seizure
usceptibility. For example, a combination of mutant alleles
n Scn2a and Kcnq2 resulted in a much more severe epilepsy
henotype than when mutations were only present in a sin-
le gene (Kearney et al., 2006). This is not something which
e can currently directly test as it requires identiﬁcation of
nambiguous mutations.
Data-mining of this linked region identiﬁed TRAK1 (traf-
cking protein, kinesin binding) and CACNA2D2 (calcium
hannel, voltage dependent, alpha 2/delta subunit 2) as the
ost plausible functional candidate genes. Both genes were
nvestigated with tagSNPs but only variants in TRAK1 demon-
trated signiﬁcant evidence for transmission disequilibrium.
his does not however deﬁnitively exclude CACNA2D2 as
G
f
c
t
Table 1 Summary of those SNPs in TRAK1 which demonstrated s
overtransmission of the minor allele in the entire resource of 63 p
SNP Number transmitted:
number not transmitted
Sum-PDT 2(1df) Z-
rs9872588 65:41 6 .88 2 .
rs9852952 59:40 5.69 2.d SNPs demonstrated evidence for transmission disequilibrium
agSNPs will only detect disease-associated alleles present
t a comparable frequency. It is possible that rare vari-
nts present in a subset of the study population will not
e detected using this methodology.
TRAK1 encodes a trafﬁcking protein originally known as
IP106 that was initially identiﬁed as a binding partner
or the enzyme -O-linked N-acetylglucosamine (O-GlcNAc)
ransferase (Iyer et al., 2003). A homozygous frameshift
utation in the mouse Trak1 gene, which produces a trun-
ated protein, was found to cause a recessively transmitted
orm of hypertonia, a neurological dysfunction characterised
y postural abnormalities, jerky movements, and tremor
Gilbert et al., 2006). Altered levels of -amino-n-butyric
cid A (GABAA) receptors observed in Trak1 mutant mice
uggested that Trak1 may also participate in the regula-
ion of GABAA receptor endosomal trafﬁcking. The protein
as been shown to interact with the GABAA receptor 1
ubunit and it has been hypothesised that Trak1 has a cru-
ial role in regulating the endocytic trafﬁcking of these
eceptors and may facilitate the targeting of endocytosed
ABAA receptors back to the cell surface or block them
rom degradation (Webber et al., 2008). In the mammalian
entral nervous system, GABA is the main inhibitory neuro-
ransmitter, activating GABAA receptors (GABAARs) on target
igniﬁcant evidence (p < 0.05 in at least one test statistic) for
edigrees and 296 trios.
score p-Value Ave-PDT 2(1df) Z-score p-Value
62 0 .009 5.48 2.34 0.019
39 0.017 4.17 2.04 0.041
Susceptibility locus for CAE on chromosome 3p23-p14 253
Figure 4 LD structure of TRAK1 based on Haploview analysis of the whole resource. Strong LD is deﬁned as D′ > 0.8. Values for
pairwise D′ (as a percentage) are given in each square except for those where D′ = 1 in which case the square is blank. Level of r2
LD is indicated by the colour of the square; the darker the square, the higher the pairwise r2 value.
Figure 5 Variants found via re-sequencing in TRAK1. ‘‘Known SNPs’’ are those which have previously been identiﬁed and can be
found in the dbSNP database. ‘‘Novel SNPs’’ are those which have not previously been identiﬁed. The ‘‘indel’’ corresponds to the
triplet repeat.
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eurones either in a phasic or a tonic fashion (Farrant and
usser, 2005; Mody and Pearce, 2004). GABAA receptors
ave been repeatedly documented to play a critical role
n animal models of seizures. The initial GABAA receptor
utations associated with the idiopathic generalised epilep-
ies were found in the 2 and 1 subunits, consistent with
genetic defect in phasic, inhibitory GABAergic synaptic
nhibition.
Intrafamilial association analysis identiﬁed two tagSNPs
howing evidence for transmission disequilibrium indicating
isease association. However, re-sequencing of the sur-
ounding region, which includes exon 2 of isoform 1, did
ot identify any putative causal variants. There are three
ain explanations for this outcome. It is possible that the
ssociation results may both be false positives; although this
s unlikely as intrafamilial association analysis is robust to
rtefacts such as population substructure. However, a Bon-
erroni style correction for multiple testing was not applied
o these analyses because although this would reduce the
isk of type I errors occurring (detection of a false pos-
tive), it would simultaneously have increased the risk of
ype II errors (missing any true associations). Thus the asso-
iation evidence described must be considered as tentative
ut requiring independent replication.
A second explanation is that the associated tagSNPs may
e in long-range LD with causal variants not identiﬁed by
he re-sequencing effort (Lawrence et al., 2005). Finally,
t is possible that the two associated tagSNPs are them-
elves causal. It remains very difﬁcult to predict the effect
f intronic variants but that does not mean that they do not
ave an effect; it has, for example, been shown that a com-
on intronic variant in the chemokine receptor gene CXCR3
s associated with gene expression levels and asthma risk
Choi et al., 2008).
In conclusion, these observations provide genetic evi-
ence of a novel susceptibility locus for childhood absence
pilepsy on chromosome 3p23-p14. Common variants show-
ng transmission disequilibrium have been identiﬁed in the
andidate gene TRAK1. Deﬁnitive evidence to conﬁrm or
xclude this gene will require re-sequencing across an
xtended genomic region encompassing TRAK1 in a larger
umber of patients and a better understanding of the role
hat non-exonic SNPs play in regulation. We have identiﬁed
large number of novel intronic and 3′ UTR SNPs, the pos-
ible function of which it is currently extremely difﬁcult to
redict. The latter, in particular, may be located within tar-
et sites for miRNA molecules, but information is lacking in
his area and it is not something which we have assessed
n detail. Replication studies in similar resources of CAE
atients are required, and future studies into the biologi-
al mechanisms of CAE could suggest other candidate genes
n the linked region which would need to be re-sequenced
o identify putative causal variants.
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